| Pharmaceutical Information |
| Drug Name |
Tolazoline hydrochloride |
| Drug ID |
BADD_D02239 |
| Description |
A vasodilator that apparently has direct actions on blood vessels and also increases cardiac output. Tolazoline can interact to some degree with histamine, adrenergic, and cholinergic receptors, but the mechanisms of its therapeutic effects are not clear. It is used in treatment of persistent pulmonary hypertension of the newborn. |
| Indications and Usage |
For the treatment of pulmonary artery anomalies |
| Marketing Status |
Discontinued |
| ATC Code |
C04AB02; M02AX02 |
| DrugBank ID |
DB00797
|
| KEGG ID |
D00997
|
| MeSH ID |
D014043
|
| PubChem ID |
6048
|
| TTD Drug ID |
D03RZV
|
| NDC Product Code |
49452-7831 |
| Synonyms |
Tolazoline | Benzalolin | Priscoline | Priscol | Tolazoline Hydrochloride | Tolazoline Monohydrochloride | Divascol | Pridazole |
|
| Chemical Information |
| Molecular Formula |
C10H13ClN2 |
| CAS Registry Number |
59-97-2 |
| SMILES |
C1CN=C(N1)CC2=CC=CC=C2.Cl |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
